Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved FluMist for self- or caregiver-administration, expanding accessibility for influenza prevention. FluMist, designed to combat influenza virus subtypes A and …
FDA Greenlights FluMist for Self- and Caregiver-Administration Read More
WASHINGTON, D.C. — In a groundbreaking move aimed at enhancing accessibility and innovation in hearing aid technology, the U.S. Food and Drug Administration (FDA) recently authorized the first over-the-counter (OTC) …
Revolutionary Hearing Aid Software Turns AirPods Pro into Accessible Hearing Solutions! Read More
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has announced the FDA‘s approval of TREMFYA® (guselkumab) for adults with moderately to severely active ulcerative colitis (UC). This chronic inflammatory condition affects …
FDA Approves TREMFYA® for Ulcerative Colitis Treatment, Promising New Hope for Patients Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved and granted emergency use authorization for the latest mRNA COVID-19 vaccines, formulated for the 2024-2025 period. This update …
FDA Approves Updated COVID-19 Vaccines Targeting Omicron Variant Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has approved the Shield test, developed by Guardant Health, Inc., for colorectal cancer (CRC) screening. This test uses blood collected in …
FDA Approves Guardant Health Blood Test for Colorectal Cancer Screening Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has secured approval from Japan’s Ministry of Health, Labor, and Welfare for its XTRAC Momentum™ 1.0 device. This advanced excimer laser, …
STRATA Skin Sciences Gains Approval for Advanced Laser Device in Japan Read More
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) has announced that China’s National Medical Products Administration (NMPA) has approved its ganaxolone oral suspension. This drug targets epileptic seizures in patients …
Marinus Pharmaceuticals Gains Approval for Seizure Drug in China Read More
PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced positive feedback from the U.S. Food and Drug Administration (FDA) on its proposal to evaluate PBFT02 for treating frontotemporal dementia (FTD) …
Passage Bio Receives FDA Support for Expanding Dementia Treatment Trial Read More
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that its lead DNA medicine candidate, INO-3107, has been granted an Innovation Passport by the U.K.’s Innovative Licensing and Access Pathway (ILAP). …
INOVIO’s DNA Medicine INO-3107 Receives U.K. Innovation Passport Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Felanorm, the first generic methimazole oral solution for treating hyperthyroidism in cats. This new medication offers a vital …
FDA Approves First Generic Methimazole Oral Solution for Cats Read More